Why Prime Movers Lab Invested in Morphoceuticals

Justin Briggs
Prime Movers Lab
Published in
7 min readFeb 15, 2023

--

Prime Movers Lab leads limb regeneration startup Morphoceuticals’ Seed Round with Juvenescence.

Because sometimes orthogonal ideas have legs. For most scientists, the lines between biology, chemistry, and physics are drawn vividly and early — separate subjects, classes, labs, careers. We are taught to categorize and classify, ascribing clever names or tortured acronyms to objects and mechanisms while perhaps overlooking deeper complexity or function. Some scientists thrive on convergence, spending their careers blurring those distinctions. Every generation or so, a few scientists come along with ideas far outside the normal distribution, with heretical insights yet profound, reproducible results, they challenge deeply rooted assumptions, overturn experimental dogma and change science forever. They are the quintessential Prime Movers; breakthrough scientists developing technologies with the potential to impact billions of lives.

Behind the breakthrough science of Morphoceuticals.

Morphoceuticals is a startup pushing regenerative medicine to new frontiers; the company has the goal to decipher the human body’s bioelectric blueprint and control morphology when impacted by disease, deformity, or injury. Prime Movers Lab led an $8M Seed investment in Morphoceuticals to back the…

--

--

Justin Briggs
Prime Movers Lab

Biologist & Partner @primemoverslab backing breakthrough science. Live to build deep tech & biotech companies. Mind pointed towards the future.